[ Price : $8.95]
CDER posts a report on Global Participation in Clinical Trials: 2015-2019 that summarizes the Centers Drug Trials Snapshot program...[ Price : $8.95]
Federal Register notice: FDA releases a final guidance describing insanitary conditions at drug compounding facilities.[ Price : $8.95]
FDA posts a final guidance on Assessing User Fees Under the Prescription Drug User Fee Amendments of 2017.[ Price : $8.95]
FDA publishes a final guidance on Enhancing the Diversity of Clinical Trial Populations Eligibility Criteria, Enrollment Practice...[ Price : $8.95]
FDA issues a final guidance discussing when a microneedling product is a device for regulatory purposes.[ Price : $8.95]
FDA implements a certification program for medical devices not exported from the U.S.[ Price : $8.95]
FDA releases a final guidance on Insanitary Conditions at Compounding Facilities.[ Price : $8.95]
Senhwa Biosciences says its clinical partner, Center for Advanced Research and Education, has received a study-may-proceed letter ...